Cumberland Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,263
Closed -$302K 180
2018
Q4
$302K Buy
+2,263
New +$371K 0.03% 145
2017
Q4
Sell
-29,978
Closed -$6.14M 66
2017
Q3
$6.14M Sell
29,978
-5,725
-16% -$1.33M 0.83% 37
2017
Q2
$8.68M Buy
35,703
+619
+2% +$145K 1.23% 32
2017
Q1
$8.38M Sell
35,084
-365
-1% -$85K 1.23% 33
2016
Q4
$7.44M Sell
35,449
-115,196
-76% -$23.9M 1.13% 32
2016
Q3
$34.7M Buy
150,645
+15,397
+11% +$3.76M 4.87% 4
2016
Q2
$31.3M Buy
135,248
+65,928
+95% +$15.2M 4.42% 8
2016
Q1
$18.6M Sell
69,320
-535
-0.8% -$153K 2.57% 17
2015
Q4
$21.8M Buy
+69,855
New +$20.8M 2.83% 20

Other funds holding AGN

Cumberland Partners's AGN Position: Q1 2019 in Review

Cumberland Partners sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,263 shares — an estimated $302K sold.

Cumberland Partners first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $34.7M in Q3 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Cumberland Partners reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Cumberland Partners sold 2,263 Allergan plc shares in Q1 2019, an estimated $302K.
  • Cumberland Partners first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
  • Cumberland Partners's Allergan plc position peaked at $34.7M in Q3 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Cumberland Partners's 13F filing for Q1 2019, filed 15 May 2019.